FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

377381003: Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3681519012 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3681520018 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym Active Entire term case insensitive SNOMED CT core module
3681521019 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym Active Entire term case insensitive SNOMED CT core module
105046901000001117 Paracetamol + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Is a Product containing phenyltoloxamine false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Is a Acetaminophen compound preparation false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Ethanolamine false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Sedating antihistamine false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Non-opioid analgesic false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Phenyltoloxamine false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Is a Product containing paracetamol and phenyltoloxamine citrate and salicylamide false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Salicylamide false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Cardiovascular agent false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance Paracetamol false Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength denominator unit Capsule true Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength denominator unit Capsule true Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength denominator unit Capsule true Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength numerator value 20 false Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient Salicylamide false Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance Salicylamide false Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient Salicylamide false Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has unit of presentation Capsule true Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient Paracetamol false Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Is a Product containing paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Count of base of active ingredient 3 false Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Is a Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance Salicylamide true Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance Phenyltoloxamine citrate true Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient Paracetamol true Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient Salicylamide true Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance Paracetamol true Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient Phenyltoloxamine citrate true Inferred relationship Existential restriction modifier 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start